EPIWORLD Publishes FY2025 Preliminary Results through Prospectus Appendix

Bulletin Express03-31

Epiworld International Co., Ltd. (“EPIWORLD”) announced that its preliminary consolidated results for the year ended 31 December 2025 have been disclosed in Appendix III of the company’s prospectus dated 20 March 2026.

The filing, released on 31 March 2026 under Hong Kong Listing Rule 13.49(1), directs shareholders and potential investors to review the financial statements on the Hong Kong Stock Exchange website (www.hkexnews.hk) and the company website (http://www.epiworld.com.cn/).

The announcement was authorized by Chairperson and Executive Director Dr. Zhao Jianhui on behalf of the Board, which currently comprises three executive directors, three non-executive directors and three independent non-executive directors.

No additional operating or financial figures beyond those already included in the prospectus were provided in the announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment